Peripheral arterial disease detection, awareness, and treatment in primary care.

By A. Hirsch, M. Criqui, D. Treat-Jacobson, Rn, J. Regensteiner, M. Creager, J. Olin, Susan H. Krook, D. Hunninghake, A. Comerota and 3 more. Journal of the American Medical Association (JAMA), 2001

1,514 citations recorded by the source corpus.

Subfields: Surgery

View Paper: https://www.semanticscholar.org/paper/b52a535f126bb4cb72e22eb7de9b6890408c8091

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Surgery

1. Robert M. Califf
2. G. Moneta
3. M. Creager
4. Massimo F. Piepoli
5. Stephen Burgess
6. S. Thompson

Citations in the corpus

• The eMERGE Network: A consortium of biorepositories linked to electronic medical records data for conducting genomic studies (2011, background): “PAD is associated with significant mortality and morbidity [12,13].”
• 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease (2016, background): “Studies have demonstrated that the majority of patients with confirmed PAD do not have typical claudication but have other non–joint-related limb symptoms or are asymptomatic (53,55).”
• Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. (2001, background): “The low sensitivity of IC for PAD may contribute to underrecognition of PAD in general medicine practices.(5,6) With its associated functional limitations, IC is appreciated as a serious clinical symptom of PAD.”
• Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). (2007, methodology): “Subjects were evaluated if they were aged 70 years or aged 50–69 years with a risk factor for vascular disease (smoking, diabetes) in 320 primary care practices in the United States.11 PAD was detected in 1865 patients which was 29% of the total population.”
• Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication. (2015, background): “Quantitative assessment includes noninvasive vascular testing, of which the cornerstone is the measurement of the ABI.”
• Peripheral artery disease: epidemiology and global perspectives (2017, methodology): “32 (22), 2851–2906 (2011), with permission from Oxford University Press and the European Society”
• Critical issues in peripheral arterial disease detection and management: a call to action. (2003, background): “9 is highly predictive of morbidity and mortality from cardiovascular events linked with PAD.(3,35,36) A comparison of detection rates reveals that the ABI is more sensitive and specific than several standard screening tests (Table 1).”